Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,995.00
+8.00 (0.40%)
Oct 1, 2026, 3:29 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 334.97 billion as of October 2, 2026. Its market cap has increased by 28.58% in one year.
Market Cap
334.97B
Enterprise Value
323.99B
Revenue
28.91B
Ranking
n/a
PE Ratio
61.88
Stock Price
1,995.00
ChartMarket Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 334.97B, an increase of 391.29%. That is a compound annual growth rate of 15.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 334.97B | 35.21% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.32T |
| Divi's Laboratories | 2.46T |
| Lenskart Solutions | 1.20T |
| Apollo Hospitals Enterprise | 1.17T |
| Emcure Pharmaceuticals | 368.85B |
| Global Health | 364.94B |
| Narayana Hrudayalaya | 353.68B |
| Wockhardt | 338.62B |